This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Big Week Ahead for Q2 Earnings, Economic Data
by Mark Vickery
Q2 earnings season unofficially begins this week, with reports anticipated from some of the biggest companies on Wall Street.
Previewing Q2 FY21 Bank Earnings
by Sheraz Mian
The overall set up for bank earnings remains positive, with the stocks likely reversing their recent interest rate-centric weakness...
Earnings Preview: UnitedHealth Group (UNH) Q2 Earnings Expected to Decline
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Molina Healthcare (MOH) appears a lucrative investment option at the moment backed by strategic initiatives and healthy revenue stream.
5 Blue-Chip Stocks to Win Big in the Second Half of 2021
by Tirthankar Chakraborty
Apple Inc (AAPL), Visa (V) & Walmart (WMT) are some of the blue-chip companies expected to gain traction along with the 120-year-old index of 30 stocks in second-half 2021.
UnitedHealth Group (UNH) Stock Moves 0.34%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $411.66 in the latest trading session, marking a +0.34% move from the prior day.
Here's Why You Should Hold on to Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is currently riding on solid top-line growth, expanding global presence and prudent capital deployment.
Anthem (ANTM) Buys MMM & Other Units From InnovaCare Health
by Zacks Equity Research
Anthem (ANTM) purchases subsidiaries of InnovaCare Health to facilitate better health outcomes across Puerto Rico.
Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Acadia Healthcare (ACHC) Forms JV to Serve Southwest Michigan
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Bronson Healthcare with an aim to provide enhanced behavioral outcomes across Battle Creek, Kalamazoo and the neighboring communities of Michigan.
4 Must-Have Growth Stocks in Your Portfolio for 2021 and Ahead
by Sapna Bagaria
Despite rich market valuation, there are attractive growth stocks, which can fetch handsome returns over the long term.
UnitedHealth Group (UNH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $400.44, moving +0.59% from the previous trading session.
UnitedHealth (UNH) Unit Opens Clinic to Ease Healthcare Access
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary Optum launches Optum Mobile Clinic, which aims to facilitate easy access to quality healthcare services across 10 U.S. counties.
Forget Clover Health (COLV), Buy 3 Non-Meme Healthcare Bets Instead
by Sapna Bagaria
Despite being hotly traded on social-media platforms, Cover Health (CLOV) offers little investment value to long-term investors.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $395.56, marking a -0.79% move from the previous day.
The Zacks Analyst Blog Highlights: Apple, Caterpillar, The Home Depot, Dow and UnitedHealth Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Caterpillar, The Home Depot, Dow and UnitedHealth Group
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2021
by Riya Anand
Fundamentally-sound stocks like Henry Schein (HSIC), UnitedHealth Group (UNH) and Phibro Animal Health (PAHC) are trading at a discount and make great picks for the long term.
Top 6 Blue-Chip Picks to Tap Dow's Comeback Rally
by Nalak Das
We have narrowed down our search to six Dow stocks that have strong growth potential for 2021. These are AAPL, HD, WMT, CAT, UNH and DOW.
This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Encompass Health, Select Medical Holdings and DaVita
Obamacare Upheld in Recent Rulings: A Boon for Healthcare
by Sapna Bagaria
Insurers and hospital companies are now in conducive regulatory environment with the ACA getting a thumbs up from the Supreme Court.
Save Your Portfolio From Inflation With Four Healthcare Stocks
by Zacks Equity Research
Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.
Humana's (HUM) Unit Unveils Centers for Serving South Louisiana
by Zacks Equity Research
Humana's (HUM) CenterWell brand introduces plans to open four centers offering enhanced healthcare services to South Louisiana's senior patients.
Avantor, Inc. (AVTR) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amazon's Physical Pharmacy Not a Grave Threat: 3 Stocks to Buy
by Urmimala Biswas
Investors should not lose optimism and continue to discover the enormous business opportunities this retail pharmacy- drug store industry holds. Here are three stocks, WMT, UNH, HLF, which you can grab now.